Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Dununu.com Dununu

Sponsorluk

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

RSS Feed Business

Posted

96

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Please log in to like, share and comment!

Middle East crisis: Donald Trump to leave G7 summit early over Iran-Israel conflict; warns Tehran to evacuate 'immediately'

Amid escalating tensions between Israel and Iran, US President Donald Trump will depart the G7...

By 0 12

Fortify the provincial structure for political stability

Nepal currently has a coalition government of major political parties like the Nepali Congress...

By 0 13

Supreme Court lawyer body slams ED notice to senior advocate

By 0 13

Housefull 5 inches closer to Rs 160 crore mark

Housefull 5 is a box office success. The comedy film stars Akshay Kumar, Abhishek Bachchan, and...

By 0 18

Today’s foreign currency exchange rates

KATHMANDU: Nepal Rastra Bank has published the foreign currency exchange rates for today...

By 0 22